tetano
Editor, Senior Moderator
Trop Med Infect Dis
. 2023 Aug 25;8(9):426.
doi: 10.3390/tropicalmed8090426. Monitoring SARS-CoV-2 Seroprevalence in Domestics and Exotic Animals in Southern France
Bachirou Tinto[SUP] 1 2 [/SUP], Justine Revel[SUP] 2 [/SUP], Laurie Virolle[SUP] 3 [/SUP], Baptiste Chenet[SUP] 3 [/SUP], Florence Reboul Salze[SUP] 4 [/SUP], Alix Ortega[SUP] 5 [/SUP], Marielle Beltrame[SUP] 5 [/SUP], Yannick Simonin[SUP] 2 [/SUP]
Affiliations
Since late 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a significant global threat to public health. Responsible for the COVID-19 pandemic, this new coronavirus has prompted extensive scientific research to comprehend its transmission dynamics, especially among humans. However, as our understanding deepens, it becomes increasingly clear that SARS-CoV-2's impact goes beyond human populations. Recent investigations have illuminated the transmission of the virus between humans and various animal species, raising important questions about zoonotic spillover events and their potential implications for both human and animal health. Our study set out to investigate the prevalence of SARS-CoV-2 in domestic animals (dogs and cats) and zoo animals in the south of France in 2021 and 2022, covering pre-Omicron and Omicron waves. We identified evidence of SARS-CoV-2 antibodies not only in domestic dogs and cats but also in several mammals in zoos. This study shows the importance of implementing surveillance measures, including serological studies, to identify and monitor cases of SARS-CoV-2 infection in animals.
Keywords: SARS-CoV-2; cats; dogs; exotic animals; seroprevalence.
. 2023 Aug 25;8(9):426.
doi: 10.3390/tropicalmed8090426. Monitoring SARS-CoV-2 Seroprevalence in Domestics and Exotic Animals in Southern France
Bachirou Tinto[SUP] 1 2 [/SUP], Justine Revel[SUP] 2 [/SUP], Laurie Virolle[SUP] 3 [/SUP], Baptiste Chenet[SUP] 3 [/SUP], Florence Reboul Salze[SUP] 4 [/SUP], Alix Ortega[SUP] 5 [/SUP], Marielle Beltrame[SUP] 5 [/SUP], Yannick Simonin[SUP] 2 [/SUP]
Affiliations
- PMID: 37755888
- DOI: 10.3390/tropicalmed8090426
Since late 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has emerged as a significant global threat to public health. Responsible for the COVID-19 pandemic, this new coronavirus has prompted extensive scientific research to comprehend its transmission dynamics, especially among humans. However, as our understanding deepens, it becomes increasingly clear that SARS-CoV-2's impact goes beyond human populations. Recent investigations have illuminated the transmission of the virus between humans and various animal species, raising important questions about zoonotic spillover events and their potential implications for both human and animal health. Our study set out to investigate the prevalence of SARS-CoV-2 in domestic animals (dogs and cats) and zoo animals in the south of France in 2021 and 2022, covering pre-Omicron and Omicron waves. We identified evidence of SARS-CoV-2 antibodies not only in domestic dogs and cats but also in several mammals in zoos. This study shows the importance of implementing surveillance measures, including serological studies, to identify and monitor cases of SARS-CoV-2 infection in animals.
Keywords: SARS-CoV-2; cats; dogs; exotic animals; seroprevalence.